| Literature DB >> 27733697 |
Elizabeth Gross1, Brent Davis2, Kenneth L Ho3, Daniel J Bates2, Heather A Harrington4.
Abstract
Researchers working with mathematical models are often confronted by the related problems of parameter estimation, model validation and model selection. These are all optimization problems, well known to be challenging due to nonlinearity, non-convexity and multiple local optima. Furthermore, the challenges are compounded when only partial data are available. Here, we consider polynomial models (e.g. mass-action chemical reaction networks at steady state) and describe a framework for their analysis based on optimization using numerical algebraic geometry. Specifically, we use probability-one polynomial homotopy continuation methods to compute all critical points of the objective function, then filter to recover the global optima. Our approach exploits the geometrical structures relating models and data, and we demonstrate its utility on examples from cell signalling, synthetic biology and epidemiology.Entities:
Keywords: chemical reaction networks; maximum-likelihood; model validation; parameter estimation; polynomial optimization
Mesh:
Year: 2016 PMID: 27733697 PMCID: PMC5095207 DOI: 10.1098/rsif.2016.0256
Source DB: PubMed Journal: J R Soc Interface ISSN: 1742-5662 Impact factor: 4.118
Algorithm 1: model validation.
| input | model |
| output | |
| 1 | If |
| 2 | If |
| else, go to step 3. | |
| 3 | Find a pair |
| 4 | If |
Figure 2.Simple example demonstrating model compatibility following algorithm 1. For ease of illustrating the main idea, we use α instead of in this figure.
Figure 1.Schematic of numerical algebraic geometry framework corresponding to algorithms 1–3. (a) Input to algorithms include model (system of polynomials) translated into a model variety (red), and steady-state data translated into a data variety (blue). (b) Flow chart of model compatibility, parameter estimation and model selection methods. Examples (green) are described in §4.
Figure 3.MAP kinase model selection using 36 data points from three model variables (aggregate phosphoforms of ERK) taken in triplicate at each of 12 EGF stimulation levels.